Summary of the research methodologies. by Vivat Keawdounglek (9710710)

“…In the downstream operation, which refers to the consumers, this study included a questionnaire to measure the level of agreement for the different factors by using the One Way ANOVA at the 0.05 level of significance. …”

CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

“…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”

Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

“…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”

Participant characteristics. by Ronald Kusolo (13200268)

“…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

“…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

“…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”

Purposive Sampling of Traditional Lanna Restaurants. by Vivat Keawdounglek (9710710)

Distribution of background characteristics of the study participants (N = 18255). by Zahid Hasan Khan (6281396)

OPV coverage by nationwide and at study areas (as per enrollment period). by Zahid Hasan Khan (6281396)

Reasons given by parents/guardians of incompletely vaccinated children (Zero-dose and one-dose OPV vaccination). by Zahid Hasan Khan (6281396)

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

A trend in discussions about the endemic blues and daily responsibilities. by Seoyoung Kim (2603596)

DataSheet1_Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR... by Colton Ladbury (19768281)

Changes in the expression of inflammatory cytokines in BALF of mice exposed to continuous CS inhalation. by Yue He (385239)

Changes in lung function of mice exposed to continuous inhalation of CS. by Yue He (385239)

Changes in inflammatory cell count in BALF of mice exposed to continuous CS inhalation. by Yue He (385239)

Group-level distributions of magnitude-squared coherence (MSC) changes across theta, alpha, beta, and broadband gamma physiological frequency bands. by Kara M. Donovan (21445866)

“…Asterisks depict differences from zero (green asterisks indicate an increase, red asterisks indicate a decrease), while pairwise differences can be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0310917#pone.0310917.s002" target="_blank">S2 Table</a>. …”

Effects of bortezomib/venetoclax on the growth suppression of sLCL 381 xenografts in SCID mice. by Kam Pui Tam (19746865)